News

Filter

Current filters:

GlaxoSmithKline

226 to 235 of 97217 results

NICE reverses October decision and approves Roche's Gazyvaro

NICE reverses October decision and approves Roche's Gazyvaro

02-12-2014

The UK’s National Institute for Health and Care Excellence (NICE) has reversed its decision on Gazyvaro…

GazyvaroOncologyPharmaceuticalRegulationRocheUK

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

Medical Research Council develops XNAzyme, a world-first synthetic enzyme

01-12-2014

Scientists from the UK's Medical Research Council have created the world’s first artificial enzymes…

BiotechnologyChemistryGeneticsMedical Research CouncilResearchUK

Novartis’ fingolimod fails to meet endpoint in primary progressive multiple sclerosis study

Novartis’ fingolimod fails to meet endpoint in primary progressive multiple sclerosis study

01-12-2014

Swiss drug major Novartis’ has announced that its Phase III INFORMS study in primary progressive multiple…

CNS DiseasesfingolimodGilenyaNovartisPharmaceuticalResearchSwitzerland

Two batches of Novartis' Fluad taken off market for investigation in Italy after 13 deaths

Two batches of Novartis' Fluad taken off market for investigation in Italy after 13 deaths

01-12-2014

The Italian Medicines Agency (AIFA) has suspended two batches of Swiss drug major Novartis’ Fluad seasonal…

Anti-viralsFluadItalian Medicines AgencyItalyNovartisPharmaceuticalRegulation

Sources say GSK to cut hundreds of jobs in the US following oncology business sale to Novartis

Sources say GSK to cut hundreds of jobs in the US following oncology business sale to Novartis

01-12-2014

Sources close to the company have said UK pharma major GlaxoSmithKline is to announce hundreds of job…

AdvairGSKOncologyPharmaceuticalProductionSocial IssuesUSA

Nippon Kayaku launches biosimilar Remicade in Japan

Nippon Kayaku launches biosimilar Remicade in Japan

01-12-2014

Japanese drugmaker Nippon Kayaku has launched the sale of Infliximab BS for IV Infusion 100mg, a biosimilar…

Anti-Arthritics/RheumaticsBiosimilarsGenericsinfliximabJapanJohnson & JohnsonMarkets & MarketingNippon KayakuRemicade

LIF explains new rules for Danish health care professionals and Pharma relations

LIF explains new rules for Danish health care professionals and Pharma relations

01-12-2014

In Denmark, new rules took effect on Saturday, November 1 to ensure greater transparency about relations…

DenmarkLifMedicinePharmaceuticalRegulation

AbbVie signs agreement with Medicines Patent Pool for lopinavir and retonavir in pediatric HIV

AbbVie signs agreement with Medicines Patent Pool for lopinavir and retonavir in pediatric HIV

01-12-2014

US drugmaker AbbVie and the Medicines Patent Pool have agreed a licensing agreement for lopinavir and…

AbbVieAnti-viralsLopinavirPharmaceuticalResearchRitonavir TabletsUSA

226 to 235 of 97217 results

Back to top